• Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2
  • Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2
  • Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2
  • Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2
  • Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2
  • Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2

Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2

Powder: Yes
Customized: Customized
Certification: GMP, ISO 9001, USP
Suitable for: Adult
State: Solid
Purity: >99%
Samples:
US$ 0/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2020

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company, Group Corporation

Basic Info.

Model NO.
PHA001
Transport Package
as Required
Specification
25kgs packaging Fiber drum outside and plastic bag
Trademark
ALLRIGHT G. C.
Origin
Shandong
Production Capacity
17000 Kilogram/Kilograms Per Month

Product Description

Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2
Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2

Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2
Cefuroxime sodium is a second-generation cephalosporin antibiotic. The antibacterial activity against Gram-positive cocci is similar or slightly worse than the first-generation cephalosporin, but the β-lactamase produced by Staphylococcus and Gram-negative bacilli is quite stable. Methicillin-resistant Staphylococcus, Enterococcus and Listeria are resistant, and other positive cocci (including anaerobic bacteria) are sensitive to this product. The antibacterial activity against Staphylococcus aureus is worse than that of cefazolin. It has strong antibacterial activity against Haemophilus influenzae, and Escherichia coli and Proteus mirabilis are sensitive to this product; Proteus mirabilis, Citrobacter and Acinetobacter have poor sensitivity to this product, Sharay Most of the genus are resistant, and Pseudomonas aeruginosa, Campylobacter and Bacteroides fragilis are resistant to this product.

Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2

1. Respiratory tract infections: acute and chronic bronchitis, bronchiectasis complicated with infection, bacterial pneumonia, lung abscess and postoperative thoracic infection.
2. ENT infection: sinusitis, tonsillitis, pharyngitis.
3. Urinary tract infection: acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria.
4. Skin and soft tissue infections: cellulitis, erysipelas, peritonitis, and traumatic infections.
5. Bone and joint infections: osteomyelitis and septic arthritis.
6. Obstetrics and gynecological infections: pelvic inflammatory disease.
7. Gonorrhea: especially suitable for those who should not be treated with penicillin.
8. Other infections: including sepsis and meningitis; abdominal pelvic and orthopedic surgery; heart, lung, esophagus and vascular surgery; prevention of infection during total joint replacement surgery.

Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2
1. Lower respiratory tract infection: such as acute bronchitis and acute exacerbation of chronic bronchitis and pneumonia.
2. Upper respiratory tract infection: including ear, nose, throat infections, such as otitis media, sinusitis, tonsillitis and pharyngitis.
3. Genitourinary infections: such as pyelonephritis, cystitis and urethritis.
4. skin and soft tissue infections: such as furunculosis, pyoderma and impetigo. Treatment of adults and early Lyme disease in children over 12 years of age, and subsequent prevention of late Lyme disease.
5. Gonorrhea: acute without complications of Neisseria gonorrhoeae urethritis and cervicitis.
Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2

Test items

Specifications

Results

Description

White or faintly yellow powder

Conforms

Identification

By HPLC

Conforms

 

It responds to the tost of sodium

Conforms

PH

Between 6.0 and 8.5

6.9

Water

Not more than 3.5%

0.026

Residual solvents

Ethanol not more than 0.50%

Conforms

 

Acctone not more than 0.50%

Conforms

Particulate mater

Partiicles>25um:not more than 600part/g

244

Sterllity

It complies with the test for sterility

Conforms

Bacterial endotoxins

Loss than 0.10EU/mg

Conforms

Assay

855ug/mg to 1000ug/mg

Conforms

Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2Supply Cefuroxime Powder/Cefuroxime Sodium CAS 56238-63-2
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2020

Suppliers with verified business licenses

Manufacturer/Factory, Trading Company, Group Corporation
Registered Capital
1000000 RMB
Plant Area
501~1000 square meters